+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients



Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients



Lancet 336(8706): 52-53




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041911512

Download citation: RISBibTeXText

PMID: 1973232

DOI: 10.1016/0140-6736(90)91564-Q


Related references

Adjuvant ursodeoxycholic acid prevents acute rejection in liver transplant recipients. Transplantation Proceedings 23(3): 1971-1971, 1991

Does adjuvant ursodeoxycholic acid prevent early rejection in liver transplant recipients. Gastroenterology 98(5 PART 2): A587, 1990

Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients. Gastroenterology 108(4 SUPPL ): A1168, 1995

Does prophylactic ursodeoxycholic acid treatment of liver transplant patients prevent acute rejection?. Hepatology 27(6): 1748-1749, 1998

A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection. Liver Transplantation and Surgery 4(4): 276-279, 1998

Delay of hepatitis C recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction. Transplantation Proceedings 34(5): 1561-1562, 2002

The effect of ursodeoxycholic acid of liver transplant rejection in the rat. Clinical & Investigative Medicine 16(4 SUPPL ): B139, 1993

Effect of ursodeoxycholic acid treatment for cholestasis in liver transplant recipients. Transplantation Proceedings 27(6): 3501-3502, 1995

Cyclosporin A pharmacokinetics in liver transplant recipients effect of ursodeoxycholic acid. Gastroenterology 118(4 Suppl 2 Part 1): AASLD A984, April, 2000

Outcomes after complete immunosuppression withdrawal in liver transplant recipients: rejection-free graft tolerance or late acute rejection?. Canadian Journal of Gastroenterology 12(6): 387-389, 1998

Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients. Fundamental & Clinical Pharmacology 14(6): 601-609, November-December, 2000

Ursodeoxycholic acid modulates cyclosporin A oral absorption in liver transplant recipients. Fundamental & Clinical Pharmacology 14(6): 601-609, 2001

Mycophenolic acid concentration profiles may select recipients with high-risk of acute rejection in renal transplant recipients. Polski Merkuriusz Lekarski 21(122): 161-3; Discussion 164, 2006

A randomized clinical trial of ursodeoxycholic acid as adjuvant treatment to prevent liver transplant rejection. Hepatology 26(4): 853-857, 1997

Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes. Clinical Transplantation 19(2): 279-285, 2005